Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: recognition of a novel conformational epitope. 2007

Tomoyuki Shiota, and Michio Okame, and Sayaka Takanashi, and Pattara Khamrin, and Makiko Takagi, and Kenji Satou, and Yuichi Masuoka, and Fumihiro Yagyu, and Yuko Shimizu, and Hideki Kohno, and Masashi Mizuguchi, and Shoko Okitsu, and Hiroshi Ushijima
Department of Developmental Medical Sciences, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Tokyo, Japan.

Norovirus, which belongs to the family Caliciviridae, is one of the major causes of nonbacterial acute gastroenteritis in the world. The main human noroviruses are of genogroup I (GI) and genogroup II (GII), which were subdivided further into at least 15 and 18 genotypes (GI/1 to GI/15 and GII/1 to GII/18), respectively. The development of immunological diagnosis for norovirus had been hindered by the antigen specificity of the polyclonal antibody. Therefore, several laboratories have produced broadly reactive monoclonal antibodies, which recognize the linear GI and GII cross-reactive epitopes or the conformational GI-specific epitope. In this study, we characterized the novel monoclonal antibody 14-1 (MAb14-1) for further development of the rapid immunochromatography test. Our results demonstrated that MAb14-1 could recognize 15 recombinant virus-like particles (GI/1, 4, 8, and 11 and GII/1 to 7 and 12 to 15) and showed weak affinity to the virus-like particle of GI/3. This recognition range is the broadest of the existing monoclonal antibodies. The epitope for MAb14-1 was identified by fragment, sequence, structural, and mutational analyses. Both terminal antigenic regions (amino acid positions 418 to 426 and 526 to 534) on the C-terminal P1 domain formed the conformational epitope and were in the proximity of the insertion region (positions 427 to 525). These regions contained six amino acids responsible for antigenicity that were conserved among genogroup(s), genus, and Caliciviridae. This epitope mapping explained the broad reactivity and different titers among GI and GII. To our knowledge, we are the first group to identify the GI and GII cross-reactive monoclonal antibody, which recognizes the novel conformational epitope. From these data, MAb14-1 could be used further to develop immunochromatography.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002213 Capsid The outer protein protective shell of a virus, which protects the viral nucleic acid. Capsids are composed of repeating units (capsomers or capsomeres) of CAPSID PROTEINS which when assembled together form either an icosahedral or helical shape. Procapsid,Prohead,Capsids,Procapsids,Proheads
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D017354 Point Mutation A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair. Mutation, Point,Mutations, Point,Point Mutations

Related Publications

Tomoyuki Shiota, and Michio Okame, and Sayaka Takanashi, and Pattara Khamrin, and Makiko Takagi, and Kenji Satou, and Yuichi Masuoka, and Fumihiro Yagyu, and Yuko Shimizu, and Hideki Kohno, and Masashi Mizuguchi, and Shoko Okitsu, and Hiroshi Ushijima
August 2010, Virus research,
Tomoyuki Shiota, and Michio Okame, and Sayaka Takanashi, and Pattara Khamrin, and Makiko Takagi, and Kenji Satou, and Yuichi Masuoka, and Fumihiro Yagyu, and Yuko Shimizu, and Hideki Kohno, and Masashi Mizuguchi, and Shoko Okitsu, and Hiroshi Ushijima
February 2015, Clinical and vaccine immunology : CVI,
Tomoyuki Shiota, and Michio Okame, and Sayaka Takanashi, and Pattara Khamrin, and Makiko Takagi, and Kenji Satou, and Yuichi Masuoka, and Fumihiro Yagyu, and Yuko Shimizu, and Hideki Kohno, and Masashi Mizuguchi, and Shoko Okitsu, and Hiroshi Ushijima
January 2012, Scientific reports,
Tomoyuki Shiota, and Michio Okame, and Sayaka Takanashi, and Pattara Khamrin, and Makiko Takagi, and Kenji Satou, and Yuichi Masuoka, and Fumihiro Yagyu, and Yuko Shimizu, and Hideki Kohno, and Masashi Mizuguchi, and Shoko Okitsu, and Hiroshi Ushijima
September 2016, Journal of virology,
Tomoyuki Shiota, and Michio Okame, and Sayaka Takanashi, and Pattara Khamrin, and Makiko Takagi, and Kenji Satou, and Yuichi Masuoka, and Fumihiro Yagyu, and Yuko Shimizu, and Hideki Kohno, and Masashi Mizuguchi, and Shoko Okitsu, and Hiroshi Ushijima
November 2010, Applied biochemistry and biotechnology,
Tomoyuki Shiota, and Michio Okame, and Sayaka Takanashi, and Pattara Khamrin, and Makiko Takagi, and Kenji Satou, and Yuichi Masuoka, and Fumihiro Yagyu, and Yuko Shimizu, and Hideki Kohno, and Masashi Mizuguchi, and Shoko Okitsu, and Hiroshi Ushijima
May 1997, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Tomoyuki Shiota, and Michio Okame, and Sayaka Takanashi, and Pattara Khamrin, and Makiko Takagi, and Kenji Satou, and Yuichi Masuoka, and Fumihiro Yagyu, and Yuko Shimizu, and Hideki Kohno, and Masashi Mizuguchi, and Shoko Okitsu, and Hiroshi Ushijima
April 2022, Protein expression and purification,
Tomoyuki Shiota, and Michio Okame, and Sayaka Takanashi, and Pattara Khamrin, and Makiko Takagi, and Kenji Satou, and Yuichi Masuoka, and Fumihiro Yagyu, and Yuko Shimizu, and Hideki Kohno, and Masashi Mizuguchi, and Shoko Okitsu, and Hiroshi Ushijima
June 2021, Applied microbiology and biotechnology,
Tomoyuki Shiota, and Michio Okame, and Sayaka Takanashi, and Pattara Khamrin, and Makiko Takagi, and Kenji Satou, and Yuichi Masuoka, and Fumihiro Yagyu, and Yuko Shimizu, and Hideki Kohno, and Masashi Mizuguchi, and Shoko Okitsu, and Hiroshi Ushijima
November 1991, Journal of virology,
Tomoyuki Shiota, and Michio Okame, and Sayaka Takanashi, and Pattara Khamrin, and Makiko Takagi, and Kenji Satou, and Yuichi Masuoka, and Fumihiro Yagyu, and Yuko Shimizu, and Hideki Kohno, and Masashi Mizuguchi, and Shoko Okitsu, and Hiroshi Ushijima
July 2008, Virology journal,
Copied contents to your clipboard!